Jump to content

Peter Sleight

Add links
From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Dl2000 (talk | contribs) at 01:54, 30 September 2016 (en-GB). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Peter Sleight
Born
Boston Spa, Yorkshire, United Kingdom
NationalityBritish
EducationCambridge University
St Bartholomew's Hospital
Oxford University
Known forChronic heart failure research
Aspirin research
Cardiac pacemaker research
Medical career
ProfessionMedicine
InstitutionsOxford University
St George's Hospital Medical School
Sub-specialtiesCardiology

Professor Peter Sleight M.D.(Cantab.), D.M.(Oxon.) FRCP FACC (born 27 June 1929)[1] is a distinguished internationally known research cardiologist [2] and an Honorary Consultant Physician at the John Radcliffe Hospital in Oxford and the Oxford University Radcliffe NHS Trust. Consultant physician/cardiologist firstly at the Radcliffe Infirmary in Oxford since 1964. Sleight is Emeritus Field Marshal Alexander Professor of Cardiovascular Medicine at the University of Oxford and an Emeritus Fellow of Exeter College, Oxford.[3]

Overview

Peter Sleight was a consultant physician/cardiologist in Oxford from 1964. He retired from the British Heart Foundation (BHF)-sponsored Field Marshal Alexander Chair of Cardiovascular Medicine in 1994, but continued to work at the John Radcliffe Hospital in Oxford. He is Deputy Chairman of the HPS Steering Committee.[4]

Sleight is a Fellow of the American College of Cardiology and an authority in the field of Cardiology research. He has served on the editorial board for many cardiology journals in the world such as Cardiovascular Research, Cardiovascular Risk, Circulation, Hypertension, the British Heart Journal, Clinical & Experimental Physiology & Pharmacology, and the Journal of Ambulatory Monitoring. He has peer reviewed articles and co-authored scientific papers on topics such as blood pressure monitoring and control, autonomic control of the circulation, prognostic value of measures of heart rate variability, and pathophysiology of ischaemic heart disease, heart failure, and hypertension in journals such as Lancet, New England Journal of Medicine, Circulation, Heart, European Heart Journal, the British Medical Journal and Clinical Science.[5]

Sleight is a world leading eminent cardiologist [6] and has co-authored and been cited in hundreds of text books in the field of Cardiology.[7][8]

Sleight is currently[when?] President of the World Hypertension League and serves as chair of the ISIS group steering committee and the related coronary prevention studies coordinated by the Clinical Trials Service Unit in Oxford.[citation needed] Previously, he was a consultant physician/cardiologist in Oxford beginning in 1964. He retired from the BHF-sponsored Field Marshal Alexander Chair of Cardiovascular Medicine in 1994.

Education

Sleight was educated at Leeds Grammar School and Gonville and Caius College, Cambridge. Studied Medicine at Cambridge University and at St Bartholomew's Hospital Medical School.)[1]

Career

Medical career

In 1964, Consultant Cardiologist Dr Peter Sleight in conjunction with Cardiac Surgeon Dr Alf Gunning [9][10] from South Africa performed one of the first pioneering operations to install an external Lucas cardiac pacemaker on a patient in her early 30s at the Radcliffe Infirmary in Oxford. This involved attaching circular coils internally to the patient's heart and with coils aligned on the outside skin of the patient to transfer the electrical charge from the Artificial cardiac pacemaker connected to external batteries. The patient had previously spent many months connected to a filing cabinet size artificial heart machine known as the "fire engine" because of its red colour .[11][12]

Sleight has done over 50 years service working for the National Health Service.

Research career

Sleight is accredited for being the first to carry out studies of the effect of Aspirin on cardiac function and stroke prevention in the early 1970s.[3] Sleight is Emeritus Professor of Cardiovascular Medicine at Oxford University.[13] Sleight and his research team at Oxford led the way and formed the foundation for the research into the use of aspirin in the prevention of other medical conditions.

Sleight is an active leading contributor to the field of cardiology research.[citation needed][when?] As chair of the ISIS group steering committee he has been involved in several significant international trials in cardiology, such as the use of Aspirin (ISIS-2), Thrombolysis (ISIS 2&3), ACE Inhibitors (HOPE) and Statins (HPS). He has served and continues to serve and on several data monitoring committees of major clinical trials, including Gusto, ECLA, ASCOT, ADVANCE, EUCLID, MODEST, CREATE, OASIS 5-7, COMMIT, VALUE, PACE, SCOUT, RELY, ORIGIN, GISSI-HF, ONTARGET, TRANSCEND and PrOFESS.

Recent research[when?] has assessed the prognostic value of measures of heart rate variability, and pathophysiological processes underlying the changes found in patients prone to ischaemic heart disease, heart failure, and hypertension.[14]

Awards

Peter Sleight is the recipient of a number of awards, including the American College of Cardiology (ACC) Young Investigator's Award in 1963, the Evian Award for Medicine and Science, International Society of Hypertension - MSD Award for distinguished research, the Galen Medal for Therapeutics 2000 (Society of Apothecaries), the Mackenzie Medal, British Cardiac Society, Louis Bishop Lecturer American College of Cardiology, the Alberto Zanchetti Lifetime Achievement Award, Gold Medal European Society of Hypertension and a Lifetime Research Award, Russian Federation of Cardiology, Bayer International Aspirin (R) Senior Award 2000.[13]

References

  1. ^ a b 'Sleight, Prof. Peter', Who's Who 2014, A & C Black, an imprint of Bloomsbury Publishing plc, 2014; online edn, Oxford University Press, December 2013; online edn, December 2013 accessed 8 December 2013
  2. ^ "Peter J. Sleight". Academic.research.microsoft.com. Retrieved 8 January 2014.
  3. ^ a b https://web.archive.org/web/20131203042143/http://www.theheart.org/fr/documents/satellite_programs/prevention/791993/biography/sleight.html. Archived from the original on 3 December 2013. Retrieved 6 December 2013. {{cite web}}: Missing or empty |title= (help); Unknown parameter |deadurl= ignored (|url-status= suggested) (help)
  4. ^ "HPS Info : Biography : Peter Sleight". Ctsu.ox.ac.uk. Retrieved 8 January 2014.
  5. ^ "Peter Sleight | Clinical Trial Service Unit". ZoomInfo.com. Retrieved 8 January 2014.
  6. ^ "Worldwide BioMed Experts - Peter J. Sleight". BioMed World Expert. Retrieved 8 January 2014.
  7. ^ "Peter J. Sleight". Academic.research.microsoft.com. Retrieved 8 January 2014.
  8. ^ "Peter J. Sleight research papers". Medscape. Retrieved 8 January 2014.
  9. ^ "Gunning, Alfred James - Biographical entry - Plarr's Lives of the Fellows Online". Livesonline.rcseng.ac.uk. Retrieved 8 January 2014.
  10. ^ "Our history — NDS". Nds.ox.ac.uk. Retrieved 8 January 2014.
  11. ^ "British Cardiovascular Society". Bcs.com. Retrieved 8 January 2014.
  12. ^ "Treatment of chronic heart block with the Lucas induction coil pacemaker" (PDF). Heart.bmj.com. Retrieved 4 March 2014.
  13. ^ a b "Research Confirms and Points to Future Aspirin Uses For Disease Prevention - re> BERLIN, Dec. 1 /PRNewswire/". Prnewswire.com. 30 November 2000. Retrieved 8 January 2014.
  14. ^ "Prof. Peter Sleight Dept of Cardiovascular Medicine Oxford, UK, comments on the outcome of the TRANSCEND trial". Thedigitalcenter.com. 4 September 2008. Retrieved 8 January 2014.
Retrieved from "https://en.wikipedia.org/w/index.php?title=Peter_Sleight&oldid=741852033"